Cargando…
Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344)
To determine the accuracy with which Medicare claims data measure disease-free survival in elderly Medicare beneficiaries with cancer, we performed a criterion validation study. We merged gold-standard clinical trial data of 45 elderly patients with node-positive breast cancer who were treated on th...
Autores principales: | Lamont, Elizabeth B., Herndon, James E., Weeks, Jane C., Henderson, I. Craig, Earle, Craig C., Schilsky, Richard L., Christakis, Nicholas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158031/ https://www.ncbi.nlm.nih.gov/pubmed/16985253 http://dx.doi.org/10.1093/jnci/djj363 |
Ejemplares similares
-
Clinician Feedback on Using Episode Groupers with Medicare Claims Data
por: Thomas, Fred, et al.
Publicado: (2009) -
Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)
por: Fuchs, Michael A., et al.
Publicado: (2014) -
Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
por: Brown, Justin C, et al.
Publicado: (2019) -
Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects
por: Qiu, Hao, et al.
Publicado: (2016) -
Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2021)